Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL J BOYD

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1891924999
CMS profile
417510
Location
HINSDALE, IL

General Payments · PY2018–2024

$8,035.10

  • Reported across 316 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$798.74

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $798.74 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $268.37 13
Biogen, Inc. $140.56 6
Teva Pharmaceuticals USA, Inc. $137.07 7
SK Life Science, Inc. $60.97 2
BANNER LIFE SCIENCES, LLC $46.14 2
UCB, Inc. $41.55 1
NOVARTIS PHARMACEUTICALS CORPORATION $41.26 2
Lundbeck LLC $29.78 1
TG THERAPEUTICS, INC. $18.11 1
Abbott Laboratories $14.93 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,829.63 82
PY2019 $432.53 29
PY2020 $137.58 8
PY2021 $802.18 45
PY2022 $1,900.52 59
PY2023 $1,133.92 57
PY2024 $798.74 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $14.93 06/11/2024 Food and Beverage Undisputed 01/23/2026 1125326582 CMS
ABBVIE INC. $15.15 01/16/2024 Food and Beverage Undisputed 01/23/2026 1103358388 CMS
ABBVIE INC. $17.98 01/31/2024 Food and Beverage Undisputed 01/23/2026 1103358390 CMS
ABBVIE INC. $28.73 02/29/2024 Food and Beverage Undisputed 01/23/2026 1103358392 CMS
ABBVIE INC. $18.43 03/07/2024 Food and Beverage Undisputed 01/23/2026 1103358394 CMS
ABBVIE INC. $16.82 04/12/2024 Food and Beverage Undisputed 01/23/2026 1103358396 CMS
ABBVIE INC. $28.22 04/30/2024 Food and Beverage Undisputed 01/23/2026 1103358398 CMS
ABBVIE INC. $17.37 05/22/2024 Food and Beverage Undisputed 01/23/2026 1103358400 CMS
ABBVIE INC. $18.02 06/26/2024 Food and Beverage Undisputed 01/23/2026 1103358402 CMS
ABBVIE INC. $7.06 07/01/2024 Food and Beverage Undisputed 01/23/2026 1103358404 CMS
ABBVIE INC. $23.28 08/22/2024 Food and Beverage Undisputed 01/23/2026 1103358406 CMS
ABBVIE INC. $16.70 10/09/2024 Food and Beverage Undisputed 01/23/2026 1103358408 CMS
ABBVIE INC. $26.33 10/21/2024 Food and Beverage Undisputed 01/23/2026 1103358410 CMS
ABBVIE INC. $34.28 12/16/2024 Food and Beverage Undisputed 01/23/2026 1103358412 CMS
BANNER LIFE SCIENCES, LLC $25.01 02/04/2024 Food and Beverage Undisputed 01/23/2026 1147028584 CMS
BANNER LIFE SCIENCES, LLC $21.13 09/04/2024 Food and Beverage Undisputed 01/23/2026 1147031191 CMS
Biogen, Inc. $20.51 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104843950 CMS
Biogen, Inc. $20.68 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104864614 CMS
Biogen, Inc. $16.76 03/13/2024 Food and Beverage Undisputed 01/23/2026 1104831072 CMS
Biogen, Inc. $29.95 06/05/2024 Food and Beverage Undisputed 01/23/2026 1104847412 CMS
Biogen, Inc. $22.81 08/26/2024 Food and Beverage Undisputed 01/23/2026 1104845074 CMS
Biogen, Inc. $29.85 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104823038 CMS
Lundbeck LLC $29.78 11/16/2024 Food and Beverage Undisputed 01/23/2026 1145899658 CMS
Novartis Pharmaceuticals Corporation $23.33 04/17/2024 Food and Beverage Undisputed 01/23/2026 1086635575 CMS
Novartis Pharmaceuticals Corporation $17.93 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086635593 CMS
SK Life Science, Inc. $32.74 02/20/2024 Food and Beverage Undisputed 01/23/2026 1154141493 CMS
SK Life Science, Inc. $28.23 04/02/2024 Food and Beverage Undisputed 01/23/2026 1154141501 CMS
Teva Pharmaceuticals USA, Inc. $24.35 01/08/2024 Food and Beverage Undisputed 01/23/2026 1151622677 CMS
Teva Pharmaceuticals USA, Inc. $27.22 02/12/2024 Food and Beverage Undisputed 01/23/2026 1151622701 CMS
Teva Pharmaceuticals USA, Inc. $7.77 03/07/2024 Food and Beverage Undisputed 01/23/2026 1151622707 CMS
Teva Pharmaceuticals USA, Inc. $6.66 04/17/2024 Food and Beverage Undisputed 01/23/2026 1151622845 CMS
Teva Pharmaceuticals USA, Inc. $36.03 05/28/2024 Food and Beverage Undisputed 01/23/2026 1151622879 CMS
Teva Pharmaceuticals USA, Inc. $7.94 11/13/2024 Food and Beverage Undisputed 01/23/2026 1151622937 CMS
Teva Pharmaceuticals USA, Inc. $27.10 11/18/2024 Food and Beverage Undisputed 01/23/2026 1151622939 CMS
TG Therapeutics, Inc. $18.11 01/25/2024 Food and Beverage Undisputed 01/23/2026 1136874189 CMS
UCB, Inc. $41.55 11/14/2024 Food and Beverage Undisputed 01/23/2026 1143465889 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.